ASCT	autologous stem cell transplantation
AYA	adolescent and young adult
EFS	event-free survival
FISH	fluorescence in situ hybridization
GPNMB	glycoprotein non-metastatic b
HDCT	high dose chemotherapy
HER2	human epidermal growth factor receptor 2
IDH	isocitrate dehydrogenase
IGF1	insulin-like growth factor 1
MTP	muramyl tripeptide
NCCN	National Comprehensive Cancer Network
NGS	next generation sequence
NTRK	neurotrophic tyrosine receptor kinase
ORR	objective response rate
OS	overall survival
PD-1	programmed cell death-1
PD-L1	Programmed cell death-ligand 1
PFS	progression free survival
RECIST	response evaluation criteria in solid tumors
SEER	surveillance: epidemiology, and end results
TKI	tyrosine kinase inhibitor
VEGFR	vascular endothelial growth factor receptor